Early intensive and myeloablative adjuvant chemotherapy in women with high-risk breast cancer.

@article{Wrmann1998EarlyIA,
  title={Early intensive and myeloablative adjuvant chemotherapy in women with high-risk breast cancer.},
  author={Bernhard Josef W{\"o}rmann and Harald Meden and Joachim Riggert and Andreas Humpe and Gerald G. Wulf and Brigitte Koch and Maria Koehler and Walther Christian Kuhn and Wolfgang Hiddemann},
  journal={Anticancer research},
  year={1998},
  volume={18 3C},
  pages={2237-41}
}
BACKGROUND Women with breast cancer and > 10 positive lymph nodes have an unfavorable prognosis. The optimal combination and intensity of adjuvant chemotherapy is uncertain. Between July 1994 and December 1996 we treated 19 patients with early intensive followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation. PATIENTS… CONTINUE READING